QA: HARROW INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001360214_2023_HARROW_INC.pdf

Logs

Graph

Absolute values for 0001360214, HARROW INC.

  xvar xval
0 AssetsCurrent 118,260,000
1 IntangibleAssetsNetIncludingGoodwill 24,057,000
2 PropertyPlantAndEquipmentNet 3,486,000
3 remainder_Assets 11,575,000
4 LiabilitiesCurrent 18,632,000
5 LiabilitiesNoncurrent 7,332,000
6 remainder_Liabilities 104,174,000
7 CostOfGoodsAndServicesSold 25,383,000
8 SellingGeneralAndAdministrativeExpense 58,243,000
9 ResearchAndDevelopmentExpense 3,050,000
10 remainder_Expenses 75,000
11 remainder_Revenues 88,595,000
12 remainder_NetIncome -15,930,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 157,378,000
1 Liabilities 130,138,000
2 Expenses 86,751,000
3 Revenues 88,595,000
4 StockholdersEquity 27,240,000
5 NetIncome -14,086,000
6 ComprehensiveNetIncome -14,086,000
7 BaseVar 239,396,000
8 EconomicCapitalRatio 0.228

Edgar->Model Mapping

Feature Distribution

Change over Time